1. Coronary microvascular health in symptomatic patients with prior COVID-19 infection: an updated analysis.
- Author
-
Ahmed, Ahmed Ibrahim, Rifai, Mahmoud Al, Alahdab, Fares, Saad, Jean Michel, Han, Yushui, Alfawara, Moath Said, Nayfeh, Malek, Malahfji, Maan, Nabi, Faisal, Mahmarian, John J, Cooke, John P, Zoghbi, William A, and Al-Mallah, Mouaz H
- Subjects
CORONARY heart disease risk factors ,CARDIOVASCULAR diseases risk factors ,COVID-19 ,CONFIDENCE intervals ,DIABETES ,RISK assessment ,SEVERITY of illness index ,COMPARATIVE studies ,CORONARY artery disease ,RESEARCH funding ,POSITRON emission tomography ,ODDS ratio ,COVID-19 pandemic - Abstract
Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with endothelial dysfunction. We aimed to determine the effects of prior coronavirus disease 2019 (COVID-19) on the coronary microvasculature accounting for time from COVID-19, disease severity, SARS-CoV-2 variants, and in subgroups of patients with diabetes and those with no known coronary artery disease. Methods and results Cases consisted of patients with previous COVID-19 who had clinically indicated positron emission tomography (PET) imaging and were matched 1:3 on clinical and cardiovascular risk factors to controls having no prior infection. Myocardial flow reserve (MFR) was calculated as the ratio of stress to rest myocardial blood flow (MBF) in mL/min/g of the left ventricle. Comparisons between cases and controls were made for the odds and prevalence of impaired MFR (MFR < 2). We included 271 cases matched to 815 controls (mean ± SD age 65 ± 12 years, 52% men). The median (inter-quartile range) number of days between COVID-19 infection and PET imaging was 174 (58–338) days. Patients with prior COVID-19 had a statistically significant higher odds of MFR <2 (adjusted odds ratio 3.1, 95% confidence interval 2.8–4.25 P < 0.001). Results were similar in clinically meaningful subgroups. The proportion of cases with MFR <2 peaked 6–9 months from imaging with a statistically non-significant downtrend afterwards and was comparable across SARS-CoV-2 variants but increased with increasing severity of infection. Conclusion The prevalence of impaired MFR is similar by duration of time from infection up to 1 year and SARS-CoV-2 variants, but significantly differs by severity of infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF